Brief: Advaxis Applies To List Common Stock On Nasdaq Under Symbol "ADXS" - SEC Filing
12/05/2022 22:37
May 12 (Reuters) - Advaxis Inc ADXS.PK :
* ADVAXIS INC SAYS APPLIED TO LIST COMMON STOCK ON NASDAQ
UNDER
SYMBOL “ADXS” - SEC FILING
Source text for Eikon: [https://bit.ly/38nsl0s]
Further company coverage: ADXS.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors